Cargando…

Anticancer Small-Molecule Agents Targeting Eukaryotic Elongation Factor 1A: State of the Art

Eukaryotic elongation factor 1A (eEF1A) canonically delivers amino acyl tRNA to the ribosomal A site during the elongation stage of protein biosynthesis. Yet paradoxically, the oncogenic nature of this instrumental protein has long been recognized. Consistently, eEF1A has proven to be targeted by a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Han, Cai, Jiayou, Yu, Siqi, Sun, Bin, Zhang, Weicheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049629/ https://www.ncbi.nlm.nih.gov/pubmed/36982256 http://dx.doi.org/10.3390/ijms24065184

Ejemplares similares

Heck Macrocyclization in Forging Non-Natural Large Rings including Macrocyclic Drugs
por: Cai, Jiayou, et al.
Publicado: (2023)

Control of eukaryotic transcription elongation
por: Winston, Fred
Publicado: (2001)

Progress in the Development of Eukaryotic Elongation Factor 2 Kinase (eEF2K) Natural Product and Synthetic Small Molecule Inhibitors for Cancer Chemotherapy
por: Zhang, Bin, et al.
Publicado: (2021)

Small molecules targeting Pin1 as potent anticancer drugs
por: Zhang, Jing, et al.
Publicado: (2023)

State of the art in eukaryotic nitrogenase engineering
por: Burén, Stefan, et al.
Publicado: (2017)

The Design and Development of Potent Small Molecules as Anticancer Agents Targeting EGFR TK and Tubulin Polymerization
por: Ihmaid, Saleh, et al.
Publicado: (2018)

Potent Small-Molecule Inhibitors Targeting Acetylated Microtubules as Anticancer Agents Against Triple-Negative Breast Cancer
por: Kwon, Ahreum, et al.
Publicado: (2020)

Synthesis and Biological Evaluation of Small Molecules as Potential Anticancer Multitarget Agents
por: Pla-López, Alberto, et al.
Publicado: (2022)

Imidazolylpyrrolone‐Based Small Molecules as Anticancer Agents for Renal Cell Carcinoma
por: Sousa, Ana, et al.
Publicado: (2022)

Inhibition of Eukaryotic Translation Elongation by Cycloheximide and Lactimidomycin
por: Schneider-Poetsch, Tilman, et al.
Publicado: (2010)

Research Progress of Small Molecule VEGFR/c-Met Inhibitors as Anticancer Agents (2016–Present)
por: Zhang, Qian, et al.
Publicado: (2020)

Small-Molecule RAS Inhibitors as Anticancer Agents: Discovery, Development, and Mechanistic Studies
por: Shetu, Shaila A., et al.
Publicado: (2022)

State of the Art and Future Implications of SH003: Acting as a Therapeutic Anticancer Agent
por: Lee, Kangwook, et al.
Publicado: (2022)

Salinomycin as a potent anticancer stem cell agent: State of the art and future directions
por: Qi, Dan, et al.
Publicado: (2021)

An evolutionary ratchet leading to loss of elongation factors in eukaryotes
por: Atkinson, Gemma C, et al.
Publicado: (2014)

Design and Synthesis of Thiazole Scaffold-Based Small Molecules as Anticancer Agents Targeting the Human Lactate Dehydrogenase A Enzyme
por: Sharma, Dolly, et al.
Publicado: (2023)

Small-Molecule Targeting of RNA Polymerase I Activates a Conserved Transcription Elongation Checkpoint
por: Wei, Ting, et al.
Publicado: (2018)

Engineering metabolite-responsive transcriptional factors to sense small molecules in eukaryotes: current state and perspectives
por: Wan, Xia, et al.
Publicado: (2019)

Small Molecule Inhibitors of AI-2 Signaling in Bacteria: State-of-the-Art and Future Perspectives for Anti-Quorum Sensing Agents
por: Guo, Min, et al.
Publicado: (2013)

Stm1p alters the ribosome association of eukaryotic elongation factor 3 and affects translation elongation
por: Van Dyke, Natalya, et al.
Publicado: (2009)

Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase
por: Pyr Dit Ruys, Sébastien, et al.
Publicado: (2012)

Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase
por: Ruys, S. Pyr Dit, et al.
Publicado: (2012)

Recent development of ATP-competitive small molecule phosphatidylinostitol-3-kinase inhibitors as anticancer agents
por: Liu, Yu, et al.
Publicado: (2016)

Synthetic Small Molecule Modulators of Hsp70 and Hsp40 Chaperones as Promising Anticancer Agents
por: Nitzsche, Bianca, et al.
Publicado: (2023)

Hybrid cis-stilbene Molecules: Novel Anticancer Agents
por: Piekuś-Słomka, Natalia, et al.
Publicado: (2019)

A general strategy to construct small molecule biosensors in eukaryotes
por: Feng, Justin, et al.
Publicado: (2015)

AMPK and Diseases: State of the Art Regulation by AMPK-Targeting Molecules
por: Tarasiuk, Olga, et al.
Publicado: (2022)

Anticancer Agents Targeted to Sirtuins
por: Kozako, Tomohiro, et al.
Publicado: (2014)

MicroRNA-33a-5p Modulates Japanese Encephalitis Virus Replication by Targeting Eukaryotic Translation Elongation Factor 1A1
por: Chen, Zheng, et al.
Publicado: (2016)

Editorial: Small organic molecules with anticancer activity
por: Rahman, A. F. M. Motiur, et al.
Publicado: (2023)

Insights Into the Pathologic Roles and Regulation of Eukaryotic Elongation Factor-2 Kinase
por: Ballard, Darby J., et al.
Publicado: (2021)

Distinct RPA functions promote eukaryotic DNA replication initiation and elongation
por: Pike, Alexandra M, et al.
Publicado: (2023)

Anticancer properties of bromelain: State-of-the-art and recent trends
por: Pezzani, Raffaele, et al.
Publicado: (2023)

Chlorambucil-Bearing Hybrid Molecules in the Development of Potential Anticancer Agents
por: Peter, Sijongesonke, et al.
Publicado: (2023)

A Quick Guide to Small-Molecule Inhibitors of Eukaryotic Protein Synthesis
por: Dmitriev, S. E., et al.
Publicado: (2020)

Impairing Eukaryotic Elongation Factor 2 Kinase Activity Decreases Atherosclerotic Plaque Formation
por: Zhang, Peng, et al.
Publicado: (2014)

Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells
por: Sanges, C, et al.
Publicado: (2012)

Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells
por: Sanges, C, et al.
Publicado: (2012)

Cellular delivery of dinucleotides by conjugation with small molecules: targeting translation initiation for anticancer applications
por: Kleczewska, Natalia, et al.
Publicado: (2021)

Natural Anticancer Molecules and Their Therapeutic Potential
por: Zhang, Junmin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iuka77gmrqjcdsgmkbdqc879jt